Literature DB >> 29020263

2017 HIVMA of IDSA Clinical Practice Guideline for the Management of Chronic Pain in Patients Living With HIV.

R Douglas Bruce1, Jessica Merlin2, Paula J Lum3, Ebtesam Ahmed4, Carla Alexander5, Amanda H Corbett6, Kathleen Foley7, Kate Leonard8, Glenn Jordan Treisman9, Peter Selwyn10.   

Abstract

Pain has always been an important part of human immunodeficiency virus (HIV) disease and its experience for patients. In this guideline, we review the types of chronic pain commonly seen among persons living with HIV (PLWH) and review the limited evidence base for treatment of chronic noncancer pain in this population. We also review the management of chronic pain in special populations of PLWH, including persons with substance use and mental health disorders. Finally, a general review of possible pharmacokinetic interactions is included to assist the HIV clinician in the treatment of chronic pain in this population.It is important to realize that guidelines cannot always account for individual variation among patients. They are not intended to supplant physician judgment with respect to particular patients or special clinical situations. The Infectious Diseases Society of American considers adherence to these guidelines to be voluntary, with the ultimate determination regarding their application to be made by the physician in the light of each patient's individual circumstances.
© The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Year:  2017        PMID: 29020263      PMCID: PMC5848240          DOI: 10.1093/cid/cix636

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  280 in total

Review 1.  Buprenorphine: new tricks with an old molecule for pain management.

Authors:  Howard A Heit; Douglas L Gourlay
Journal:  Clin J Pain       Date:  2008-02       Impact factor: 3.442

Review 2.  Pharmacokinetic drug interactions and adverse consequences between psychotropic medications and pharmacotherapy for the treatment of opioid dependence.

Authors:  Ali S Saber-Tehrani; Robert Douglas Bruce; Frederick L Altice
Journal:  Am J Drug Alcohol Abuse       Date:  2011-01       Impact factor: 3.829

3.  Low back pain in primary care.

Authors:  Richard A Deyo; Jeffrey G Jarvik; Roger Chou
Journal:  BMJ       Date:  2014-07-16

4.  Non-fatal overdose and subsequent drug treatment among injection drug users.

Authors:  Robin A Pollini; Lisa McCall; Shruti H Mehta; David Vlahov; Steffanie A Strathdee
Journal:  Drug Alcohol Depend       Date:  2005-11-23       Impact factor: 4.492

5.  Predicting aberrant drug behavior in patients treated for chronic pain: importance of abuse history.

Authors:  Edward Michna; Edgar L Ross; Wilfred L Hynes; Srdjan S Nedeljkovic; Sharonah Soumekh; David Janfaza; Diane Palombi; Robert N Jamison
Journal:  J Pain Symptom Manage       Date:  2004-09       Impact factor: 3.612

6.  NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: results of a 52-week open-label study.

Authors:  David M Simpson; Stephen Brown; Jeffrey K Tobias; Geertrui F Vanhove
Journal:  Clin J Pain       Date:  2014-02       Impact factor: 3.442

Review 7.  Opioid dependence and addiction during opioid treatment of chronic pain.

Authors:  Jane C Ballantyne; Steven K LaForge
Journal:  Pain       Date:  2007-05-04       Impact factor: 6.961

8.  A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection. AIDS Clinical Trial Group 242 Protocol Team.

Authors:  K Kieburtz; D Simpson; C Yiannoutsos; M B Max; C D Hall; R J Ellis; C M Marra; R McKendall; E Singer; G J Dal Pan; D B Clifford; T Tucker; B Cohen
Journal:  Neurology       Date:  1998-12       Impact factor: 9.910

9.  Evaluation of the Staying Alive programme: training injection drug users to properly administer naloxone and save lives.

Authors:  Karin E Tobin; Susan G Sherman; Peter Beilenson; Christopher Welsh; Carl A Latkin
Journal:  Int J Drug Policy       Date:  2008-04-22

10.  Association between Benzodiazepine Use and Dementia: A Meta-Analysis.

Authors:  GuoChao Zhong; Yi Wang; Yong Zhang; Yong Zhao
Journal:  PLoS One       Date:  2015-05-27       Impact factor: 3.240

View more
  36 in total

1.  Older HIV-infected adults. Complex patients (III): Polypharmacy.

Authors:  Samuel F Freedman; Carrie Johnston; John J Faragon; Eugenia L Siegler; Tessa Del Carmen
Journal:  Eur Geriatr Med       Date:  2018-12-06       Impact factor: 1.710

Review 2.  Challenges Facing a Rural Opioid Epidemic: Treatment and Prevention of HIV and Hepatitis C.

Authors:  Asher J Schranz; Jessica Barrett; Christopher B Hurt; Carlos Malvestutto; William C Miller
Journal:  Curr HIV/AIDS Rep       Date:  2018-06       Impact factor: 5.071

3.  Multidisciplinary Care Models in HIV/AIDS Care: A Wholistic Approach.

Authors:  Sara D Pullen
Journal:  Rehabil Oncol       Date:  2019-01

4.  Correlates of opioid and benzodiazepine co-prescription among people living with HIV in British Columbia, Canada: A population-level cohort study.

Authors:  Stephanie Parent; Seonaid Nolan; Nadia Fairbairn; Monica Ye; Anthony Wu; Julio Montaner; Rolando Barrios; Lianping Ti
Journal:  Int J Drug Policy       Date:  2019-03-18

5.  The prevalence and patterns of substance use by birth cohort among HIV-positive adults in Florida.

Authors:  Zachary L Mannes; Vaughn E Bryant; Larry E Burrell; Huiyin Lu; Erin G Ferguson; Zhi Zhou; Robert L Cook; Nicole Ennis
Journal:  Aging Ment Health       Date:  2018-02-13       Impact factor: 3.658

6.  Cannabis Consumption in People Living with HIV: Reasons for Use, Secondary Effects, and Opportunities for Health Education.

Authors:  Cecilia T Costiniuk; Zahra Saneei; Syim Salahuddin; Joseph Cox; Jean-Pierre Routy; Sergio Rueda; Sara J Abdallah; Dennis Jensen; Bertrand Lebouché; Marie-Josée Brouillette; Marina Klein; Jason Szabo; Charles Frenette; Andreas Giannakis; Mohammad-Ali Jenabian
Journal:  Cannabis Cannabinoid Res       Date:  2019-09-23

7.  Provider opioid prescribing practices and the belief that opioids keep people living with HIV engaged in care: a cross-sectional study.

Authors:  Judith I Tsui; Alexander Y Walley; Debbie M Cheng; Marlene C Lira; Jane M Liebschutz; Leah S Forman; Margaret M Sullivan; Jonathan Colasanti; Christin Root; Kristen O'Connor; Christopher W Shanahan; Carly L Bridden; Carlos Del Rio; Jeffrey H Samet
Journal:  AIDS Care       Date:  2019-01-11

8.  Medicaid trends in prescription opioid and non-opioid use by HIV status.

Authors:  Chelsea Canan; G Caleb Alexander; Richard Moore; Irene Murimi; Geetanjali Chander; Bryan Lau
Journal:  Drug Alcohol Depend       Date:  2019-02-13       Impact factor: 4.492

9.  Physical Therapy for Chronic Pain Mitigation and Opioid Use Reduction Among People Living with Human Immunodeficiency Virus in Atlanta, GA: A Descriptive Case Series.

Authors:  Sara D Pullen; Christi Acker; Haemi Kim; Morgan Mullins; Payton Sims; Holly Strasbaugh; Samantha Zimmerman; Carlos Del Rio; Vincent C Marconi
Journal:  AIDS Res Hum Retroviruses       Date:  2020-06-02       Impact factor: 2.205

10.  The impact of high-dose opioid prescription on mortality rates among people living with HIV: A retrospective cohort study.

Authors:  Saif-El-Din El-Akkad; Seonaid Nolan; Nadia Fairbairn; Monica Ye; Anthony Wu; Rolando Barrios; Julio Montaner; Lianping Ti
Journal:  Int J Drug Policy       Date:  2020-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.